ICER
ICER
  • ICER Analytics™
  • Donate
search
  • Who We Are
    • History & Impact
    • People
    • Independent Funding
    • Careers
    • Frequently Asked Questions (FAQs)
  • Our Approach
    • Methods & Process
    • Policies
  • Engage with ICER
    • Patients
    • Clinicians
    • Manufacturers
    • Prospective Employees
    • Committees & Boards
  • News & Insights
    • Press Releases
    • Commentaries
    • Journal Articles
    • Weekly View
  • Explore Our Research
    • Assessments
    • Policy Papers
    • ICER Calendar
    • ICER ANALYTICS™

Our Approach

Collaborating with stakeholders across the US healthcare system, we assess how much better a health intervention is, and what a fair price could be.

Methods & Process

Policies

Featured Reports, News & Insights.

woman listening to news at a party

ICER Publishes Final Evidence Report and Policy Recommendations on Aducanumab for Alzheimer’s Disease

Independent appraisal committee unanimously determined the evidence is not adequate to demonstrate that aducanumab provides a net health benefit.

08/05/2021

ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports, Helping Payers, the Life Science Industry, and Health Care Policy Makers Move From Insight to Action

ICER formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices.

11/30/2020

In Landmark International Program, HTA Agencies Around the World Access ICER’s Customizable COVID-19 Cost-Effectiveness Model

Leveraging ICER’s new cloud-based Interactive Modeler platform, Quebec’s HTA agency has used the COVID-19 model to inform Ministerial recommendations on remdesivir; other HTA agencies and research groups in the United Kingdom, Australia, Canada and South Africa plan to access the model.

10/09/2020
Go to News & Insights

Back to Top
  • Contact
  • Careers
  • Find a Report
  • Donate
  • ICER ANALYTICS™ LOGIN

OUR NEWSLETTER.

A weekly digest of the top news
on ICER and US drug pricing. Sign Up


CONTACT US

Institute for Clinical and Economic Review
14 Beacon Street, Suite 800, Boston, MA 02108
Get Directions

+1 (617) 528-4013

Email: info@icer.org

Media Inquiries: mediainquiries@icer.org

ICER
© ICER, 2022
  • Terms and Conditions
  • Privacy Policy
Twitter Linkedin